Hemagen Diagnostics HMGN Stock
Hemagen Diagnostics Price Chart
Hemagen Diagnostics HMGN Financial and Trading Overview
| Hemagen Diagnostics stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0001 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0001 - 0.0001 USD |
| 52 Week Range | 0.0001 - 0.0001 USD |
| Volume | 15K USD |
| Avg. Volume | 1.94K USD |
| Market Cap | 387.51K USD |
| Beta (5Y Monthly) | 0.432394 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
HMGN Valuation Measures
| Enterprise Value | 4.96M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.09586789 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1.228 |
| Enterprise Value/EBITDA | -18.132 |
Trading Information
Hemagen Diagnostics Stock Price History
| Beta (5Y Monthly) | 0.432394 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0001 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 0.0001 USD |
HMGN Share Statistics
| Avg. Volume (3 month) | 1.94K USD |
| Avg. Daily Volume (10-Days) | 1.5K USD |
| Shares Outstanding | 15.5M |
| Float | N/A |
| Short Ratio | 0 |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | 0 |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2012 |
| Most Recent Quarter (mrq) | September 30, 2012 |
| Next Fiscal Year End | September 30, 2013 |
Profitability
| Profit Margin | -22.44% |
| Operating Margin (ttm) | -10.83% |
| Gross Margin | 39.91% |
| EBITDA Margin | -6.76% |
Management Effectiveness
| Return on Assets (ttm) | -10.26% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 4.04M USD |
| Revenue Per Share (ttm) | 0.26 USD |
| Quarterly Revenue Growth (yoy) | -23.59% |
| Gross Profit (ttm) | 1.61M USD |
| EBITDA | -273664 USD |
| Net Income Avi to Common (ttm) | -907315 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 66.29K USD |
| Total Cash Per Share (mrq) | 0.004 USD |
| Total Debt (mrq) | 5.03M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.074 |
| Book Value Per Share (mrq) | -0.229 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -358687 USD |
| Levered Free Cash Flow (ttm) | -115854 USD |
Profile of Hemagen Diagnostics
| Country | United States |
| State | MD |
| City | Columbia |
| Address | 9033 Red Branch Road |
| ZIP | 21045 |
| Phone | 443-367-5500 |
| Website | https://www.hemagen.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 15 |
Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its human diagnostics products also comprise Universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines. In addition, the company provides veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas. It sells its products directly, as well as through distributors to various laboratories, hospitals, and blood banks. The company was founded in 1985 and is based in Columbia, Maryland.
Q&A For Hemagen Diagnostics Stock
What is a current HMGN stock price?
Hemagen Diagnostics HMGN stock price today per share is 0.0001 USD.
How to purchase Hemagen Diagnostics stock?
You can buy HMGN shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hemagen Diagnostics?
The stock symbol or ticker of Hemagen Diagnostics is HMGN.
Which industry does the Hemagen Diagnostics company belong to?
The Hemagen Diagnostics industry is Biotechnology.
How many shares does Hemagen Diagnostics have in circulation?
The max supply of Hemagen Diagnostics shares is 3.88B.
What is Hemagen Diagnostics Price to Earnings Ratio (PE Ratio)?
Hemagen Diagnostics PE Ratio is now.
What was Hemagen Diagnostics earnings per share over the trailing 12 months (TTM)?
Hemagen Diagnostics EPS is 0 USD over the trailing 12 months.
Which sector does the Hemagen Diagnostics company belong to?
The Hemagen Diagnostics sector is Healthcare.